Last reviewed · How we verify

Dymelor — Competitive Intelligence Brief

Dymelor (ACETOHEXAMIDE) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: acetohexamide. Area: Metabolic.

marketed acetohexamide Sulfonylurea receptor 1, Kir6.2 Metabolic Small molecule Live · refreshed every 30 min

Target snapshot

Dymelor (ACETOHEXAMIDE) — Eli Lilly.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Dymelor TARGET ACETOHEXAMIDE Eli Lilly marketed acetohexamide Sulfonylurea receptor 1, Kir6.2 1964-01-01
Starlix NATEGLINIDE Novartis marketed Glinide [EPC] Sulfonylurea receptor 1, Kir6.2 2000-01-01
Amaryl GLIMEPIRIDE Sanofi marketed Sulfonylurea [EPC] Sulfonylurea receptor 1, Kir6.2 1995-01-01
Micronase glibenclamide Sanofi marketed Sulfonylurea Sulfonylurea receptor 1, Kir6.2 1984-01-01
Glucotrol GLIPIZIDE Pfizer marketed Sulfonylurea [EPC] Sulfonylurea receptor 1, Kir6.2 1984-01-01
Proglycem DIAZOXIDE marketed diazoxide Sulfonylurea receptor 1, Kir6.2 1973-01-01
Aglicid TOLBUTAMIDE marketed Sulfonylurea Sulfonylurea receptor 1, Kir6.2 1961-01-01

Recent regulatory actions (last 90 days)

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (acetohexamide class)

  1. Eli Lilly · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Dymelor — Competitive Intelligence Brief. https://druglandscape.com/ci/acetohexamide. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: